Cellenkos
Houston
About Cellenkos
Cellenkos is a clinical-stage biotech company focused on the development and commercialization of transformative novel allogeneic Treg cell therapies to treat autoimmune and inflammatory disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.0M
- Funding stage: M&A
- Last round: Series A (Nov 2021)
- Website: cellenkosinc.com
- Phone: (800) 217-8247
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/cellenkos-30466 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.